Related Experiment Videos
Expression of two different endogenous galactoside-binding lectins sharing sequence homology
1Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Cancer Research
|February 1, 1988
Summary
Researchers studied beta-D-galactoside-binding lectins in fibrosarcoma cells, finding the Mr 34,000 lectin
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Endogenous beta-D-galactoside-binding lectins are crucial in cellular processes.
- UV-2237-IP3 fibrosarcoma cells express two lectin polypeptides: L-14.5 (14,500 Da) and L-34 (34,000 Da).
- Previous work involved constructing cDNA libraries and isolating lectin cDNA clones.
Purpose of the Study:
- To compare the structure and gene number of lectins in fibrosarcoma cells and normal mouse lung DNA.
- To investigate the differential expression of lectin mRNAs in normal versus transformed cells.
- To determine the nucleotide and amino acid sequences of the lectin cDNA clones.
Main Methods:
- Construction of complementary DNA (cDNA) libraries in lambda gt11.
- Hybridization analysis of messenger RNA (mRNA) expression.
- Nucleotide sequencing of cDNA clones.
Main Results:
- Genomic DNA structure and gene number were similar between fibrosarcoma and normal lung cells.
- mRNA for the Mr 34,000 lectin was more abundant in transformed cells.
- No significant difference in mRNA levels for the Mr 14,500 lectin was observed between cell types.
- The L-14.5 lectin cDNA sequence showed homology to other vertebrate galactoside-binding lectins.
- The Mr 34,000 lectin cDNA sequence shared a conserved 39-amino acid domain with L-14 lectins.
Conclusions:
- The conserved domain suggests a common ancestral gene for L-14 galactoside-binding lectins.
- This domain is likely essential for sugar-binding properties.
- Differential expression of the Mr 34,000 lectin mRNA may play a role in fibrosarcoma development.